
Avro Life Science
Avro Life Science is a YC Winter 2018 (W18) company. Based in Waterloo, ON, Canada. Team of 8.
About Avro Life Science
Summary
Avro Life Science develops topical drug delivery platforms that enable drug molecules to pass passively through the skin, a route that conventional formulations cannot achieve. Its technology targets medical dermatology, replacing systemic drug delivery methods with transdermal alternatives for generic and novel therapeutics. The company is at the clinical stage, advancing a pipeline of drug candidates built on its proprietary platform.
Go-to-market
Avro Life Science advances its own clinical-stage pipeline of drug candidates, positioning its platform technology toward pharmaceutical partners and the broader medical dermatology market.
From the Y Combinator listing
Skin patches for generic drug delivery.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- Waterloo, ON, Canada
- 8
- Active
- Early
Founders (2)
- Keean Sarani
- Shak Lakhani
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works